The Medical Letter on Drugs and Therapeutics
Issue 1511
Antiviral Drugs for Seasonal Influenza 2016-2017; Another Insulin Glargine (Basaglar) for Diabetes; Ustekinumab (Stelara) for Crohn's Disease; Tenofovir Alafenamide (Vemlidy) for Hepatitis B
The full issue is available to subscribers Subscriber Login   
Antiviral Drugs for Seasonal Influenza 2016-2017

Antiviral drugs can be used for prophylaxis and treatment of influenza. Frequently updated information on influenza activity, testing for influenza, and antiviral resistance is available from the CDC at

INDICATIONS FOR TREATMENT — The CDC recommends starting antiviral treatment as soon as possible after illness onset, without waiting for the results of influenza testing. Antiviral treatment is indicated for all persons with suspected or confirmed influenza who are at high risk for complications, including children <2 years old, persons <19 years old receiving long-term aspirin therapy, adults ≥65 years old, morbidly obese persons (BMI ≥40), women who are pregnant or ≤2 weeks postpartum, persons of American Indian/Alaska Native heritage, residents of nursing homes or other chronic care facilities, and persons who are immunosuppressed or ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this issue:
Title: Issue 1511
Select version:
 Downloadable, electronic issue - $35
 Postal, hardcopy issue - $35